Pathfinder
Editor, Senior Moderator
Children's swine flu vaccine recalled for ineffectiveness
By Luis Fabregas
PITTSBURGH TRIBUNE-REVIEW
Tuesday, December 15, 2009
Last updated: 3:42 pm
A nationwide recall of swine flu vaccine for infants today extended to Pennsylvania, where vaccine maker Sanofi-Aventis recalled about 15,000 of the pre-filled syringes.
Holli Senior, a spokeswoman for the Pennsylvania Department of Health, said 20 providers throughout the state received the recalled doses, but she did not immediately know specific locations.
Sanofi-Aventis recalled about 800,000 doses, saying the vaccine may be less potent than required. Officials at the U.S. Centers for Disease Control and Prevention emphasized the vaccines were safe.
"It's a potency issue, not a safety issue," Senior said.
If children have received the vaccine it would not pose any safety concerns, she said.
The infants and children who received the recalled vaccine should be protected from the H1N1 virus, provided they received the recommended two shots, said Dr. Anne Schuchat of the Centers for Disease Control and Prevention.
Len Lavenda, spokesman for Sanofi-Aventis, said the vaccine should still protect children who received two doses.
"We still believe it will protect children," he said.
He said routine tests showed four lots of the vaccine contained "a little less antigen" and "little less active ingredient" than required. Sanofi-Aventis notified federal authorities of the problem on Monday.
Since the recalled vaccine most likely was already given to children, officials issued the recall to alert providers to return any unused doses.
http://www.pittsburghlive.com/x/pittsburghtrib/news/nation/s_657858.html
By Luis Fabregas
PITTSBURGH TRIBUNE-REVIEW
Tuesday, December 15, 2009
Last updated: 3:42 pm
A nationwide recall of swine flu vaccine for infants today extended to Pennsylvania, where vaccine maker Sanofi-Aventis recalled about 15,000 of the pre-filled syringes.
Holli Senior, a spokeswoman for the Pennsylvania Department of Health, said 20 providers throughout the state received the recalled doses, but she did not immediately know specific locations.
Sanofi-Aventis recalled about 800,000 doses, saying the vaccine may be less potent than required. Officials at the U.S. Centers for Disease Control and Prevention emphasized the vaccines were safe.
"It's a potency issue, not a safety issue," Senior said.
If children have received the vaccine it would not pose any safety concerns, she said.
The infants and children who received the recalled vaccine should be protected from the H1N1 virus, provided they received the recommended two shots, said Dr. Anne Schuchat of the Centers for Disease Control and Prevention.
Len Lavenda, spokesman for Sanofi-Aventis, said the vaccine should still protect children who received two doses.
"We still believe it will protect children," he said.
He said routine tests showed four lots of the vaccine contained "a little less antigen" and "little less active ingredient" than required. Sanofi-Aventis notified federal authorities of the problem on Monday.
Since the recalled vaccine most likely was already given to children, officials issued the recall to alert providers to return any unused doses.
http://www.pittsburghlive.com/x/pittsburghtrib/news/nation/s_657858.html